Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 2 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

1
Player Avatar OOji (28.88) Submitted: 5/17/2008 8:15:00 PM : Underperform Start Price: $8.29 FLML Score: +3.90

Investing is a risky proposition.

Featured Broker Partners


Advertisement